Search Count: 29
![]()  | 
								
									
									 
										Organism: Human coronavirus oc43 
								Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2024-10-16 Classification: VIRAL PROTEIN Ligands: A1AUY  | 
							
![]()  | 
								
									
									 
										Organism: Severe acute respiratory syndrome coronavirus 2 
								Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2024-10-16 Classification: VIRAL PROTEIN Ligands: A1AUX  | 
							
![]()  | 
								
									 Co-Structure Of Main Protease Of Sars-Cov-2 (Covid-19) With Covalent Inhibitor 
									
										Organism: Severe acute respiratory syndrome coronavirus 2 
								Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2024-10-16 Classification: HYDROLASE Ligands: A1AU4  | 
							
![]()  | 
								
									 The Ternary Complex Structure Of Ddb1-Crbn-Sall4(Zf1,2)-Short Bound To Cc-220 
									
										Organism: Homo sapiens 
								Method: X-RAY DIFFRACTION Resolution:2.95 Å Release Date: 2023-12-27 Classification: LIGASE Ligands: ZN, 8W7, SO4  | 
							
![]()  | 
								
									 The Ternary Complex Structure Of Ddb1-Crbn-Sall4(Zf1,2)-Short Bound To Pomalidomide 
									
										Organism: Homo sapiens 
								Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2023-12-27 Classification: LIGASE Ligands: ZN, Y70, EDO  | 
							
![]()  | 
								
									 The Ternary Complex Structure Of Ddb1-Crbn-Sall4(Zf1,2)-Long Bound To Pomalidomide 
									
										Organism: Homo sapiens 
								Method: X-RAY DIFFRACTION Resolution:3.10 Å Release Date: 2023-12-27 Classification: LIGASE Ligands: ZN, Y70  | 
							
![]()  | 
								
									 Co-Structure Of Sars-Cov-2 (Covid-19 With Covalent Pyrazoline Based Inhibitors) 
									
										Organism: Severe acute respiratory syndrome coronavirus 2 
								Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2023-06-07 Classification: HYDROLASE, Viral Protein/Inhibitor Ligands: I3R, IMD  | 
							
![]()  | 
								
									 Co-Structure Of Sars-Cov-2 (Covid-19 With Covalent Pyrazoline Based Inhibitors 
									
										Organism: Severe acute respiratory syndrome coronavirus 2 
								Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2023-06-07 Classification: HYDROLASE Ligands: A1W  | 
							
![]()  | 
								
									 Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp4/5 (P6-P1) 
									
										Organism: Severe acute respiratory syndrome coronavirus 2 
								Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR  | 
							
![]()  | 
								
									 Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp5/6 (P6-P1) 
									
										Organism: Severe acute respiratory syndrome coronavirus 2 
								Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR  | 
							
![]()  | 
								
									 Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp6/7 (P6-P1) 
									
										Organism: Severe acute respiratory syndrome coronavirus 2 
								Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR  | 
							
![]()  | 
								
									 Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp7/8 (P6-P1) 
									
										Organism: Severe acute respiratory syndrome coronavirus 2 
								Method: X-RAY DIFFRACTION Resolution:2.02 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR  | 
							
![]()  | 
								
									 Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp8/9 (P6-P1) 
									
										Organism: Severe acute respiratory syndrome coronavirus 2 
								Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR  | 
							
![]()  | 
								
									 Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp10/11 (P6-P1) 
									
										Organism: Severe acute respiratory syndrome coronavirus 2 
								Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR  | 
							
![]()  | 
								
									
									 
										Organism: Severe acute respiratory syndrome coronavirus 2 
								Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: GOL, DMS  | 
							
![]()  | 
								
									
									 
										Organism: Severe acute respiratory syndrome coronavirus 2, Escherichia coli 
								Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: GOL, DMS  | 
							
![]()  | 
								
									
									 
										Organism: Severe acute respiratory syndrome coronavirus 2 
								Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: EDO, GOL  | 
							
![]()  | 
								
									
									 
										Organism: Severe acute respiratory syndrome coronavirus 2 
								Method: X-RAY DIFFRACTION Resolution:2.18 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: GOL  | 
							
![]()  | 
								
									
									 
										Organism: Severe acute respiratory syndrome coronavirus 2 
								Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN  | 
							
![]()  | 
								
									
									 
										Organism: Severe acute respiratory syndrome coronavirus 2 
								Method: X-RAY DIFFRACTION Resolution:2.28 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: GOL  | 
							
					



















